SCHEMBL6424969

SCHEMBL6424969

CCC(C)C[C@H](C(=O)O)c1c(C)n(C(=O)c2ccc(Cl)c(Cl)c2)c2ccc(O)c(F)c12

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.34
AKR1C3 P42330 4/20 0.34
AKR1C2 P52895 4/20 0.34
GRN P28799 1/20 0.34
SORT1 Q99523 1/20 0.34
PTGS2 P35354 5/20 0.32
PTGS1 P23219 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
APP P05067 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6425591 1.00 ABCB11 (0.34) ABCB11AKR1C3AKR1C2GRNSORT1
SCHEMBL6456480 0.94 AKR1C3 (0.33) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL6462238 0.94 AKR1C3 (0.33) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL6425032 0.92 GRN (0.40) ABCB11AKR1C3AKR1C2GRNSORT1
SCHEMBL6424377 0.92 ABCB11 (0.37) ABCB11AKR1C3AKR1C2GRNSORT1
SCHEMBL6424865 0.92 ABCB11 (0.37) ABCB11AKR1C3AKR1C2GRNSORT1
SCHEMBL6423563 0.90 AKR1C3 (0.41) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL6423900 0.90 AKR1C3 (0.41) ABCB11AKR1C3AKR1C2PTGS2PTGS1
SCHEMBL6425256 0.89 GRN (0.34) AKR1C3AKR1C2GRNSORT1PSEN1
SCHEMBL6424917 0.89 GRN (0.34) AKR1C3AKR1C2GRNSORT1PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 ABCB11 4380/4885AKR1C3 577/4885AKR1C2 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.